List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 23 studies with search of:   "Sibutramine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
Condition: Obesity
Interventions: Drug: sibutramine;   Drug: sibutramine;   Drug: sibutramine
2 Completed Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
Conditions: Obesity;   Hypertension
Interventions: Drug: sibutramine;   Drug: sibutramine;   Drug: verapamil/trandolapril;   Drug: metoprolol/HCT;   Drug: felodipine/ramipril
3 Recruiting Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Sibutramine (Meridia) and Lifestyle Intervention with exercise and diet;   Drug: Loestrin 1/20;   Drug: Sibutramine (Meridia) and Loestrin 1/20
4 Active, not recruiting A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients.
Condition: Obesity
Interventions: Drug: sibutramine hydochloride monohydrate;   Drug: placebo;   Behavioral: Diet and Exercise Counseling
5 Completed Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
Condition: Obesity
Interventions: Drug: Sibutramine;   Drug: Placebo
6 Completed A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
Condition: Obesity
Intervention: Drug: sibutramine hydochloride monohydrate
7 Terminated Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects
Conditions: Obesity;   Weight Loss
Interventions: Drug: placebo;   Drug: sibutramine or placebo
8 Recruiting Treatment of Binge Eating in Obese Patients in Primary Care
Conditions: Obesity;   Binge Eating
Interventions: Drug: Sibutramine;   Drug: Placebo;   Behavioral: Self-help CBT + Sibutramine;   Behavioral: Self-help CBT + Placebo
9 Completed A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
Condition: Obesity
Intervention: Drug: sibutramine
10 Completed A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Conditions: Overweight;   Obesity
Interventions: Drug: pramlintide acetate;   Drug: sibutramine;   Drug: phentermine;   Drug: placebo
11 Active, not recruiting Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates
Conditions: Cardiovascular Diseases;   Heart Diseases;   Obesity
Interventions: Drug: Sibutramine;   Behavioral: Behavioral Smoking Cessation Program
12 Completed Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
Conditions: Obesity;   Polycystic Ovary Syndrome
Intervention: Drug: Sibutramine
13 Completed A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Conditions: Binge Eating Disorder;   Obesity
Intervention: Drug: sibutramine
14 Completed Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
Conditions: Obstructive Sleep Apnea;   Obesity;   Hypertension
Interventions: Drug: Sibutramine;   Device: CPAP
15 Completed Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
Conditions: Obesity;   Overweight
Intervention: Drug: sibutramine
16 Completed A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
Condition: Obesity
Interventions: Drug: Nasal Placebo;   Drug: Placebo Capsule;   Drug: PYY3-36;   Drug: PYY3-36;   Drug: PYY3-36;   Drug: Sibutramine
17 Recruiting Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care
Conditions: Obesity;   Binge Eating
Interventions: Behavioral: Behavioral Weight Loss;   Behavioral: Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy;   Drug: Placebo;   Drug: Sibutramine
18 Completed The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Conditions: Schizophrenia;   Psychotic Disorders;   Bipolar Disorder
Intervention: Drug: Sibutramine
19 Completed A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects
Condition: Obesity
Interventions: Drug: CP-945,598;   Drug: sibutramine
20 Completed A Comparative Study of KES524 in Patients With Obesity Disease
Condition: Obesity
Intervention: Drug: Sibutramine Hydrochloride Monohydrate

Previous Page Studies Shown (1-20) Next (21-23)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services